Overall rank by patents
#32,031
of 49,997 tracked assignees
USPTO PatentsView assignee record - 8 granted patents across 6 technology areas, recorded in grant years 2018–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).
The verdict
According to USPTO PatentsView, In2bones ranks #32,031 of 49,997 tracked US assignees by granted-patent volume, with 8 patents across 6 technology areas.
USPTO PatentsView assignee plate
Corpus R32031 · US Corporation #32,031 · 8 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-UP · BOOK-FULL
Nearest grant-volume peer: Imperial Pools, Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
In2Bones · this assignee
28 score
3D Lighting… · lowest
7 score
What this shows In2bones's Innovation Score is 27.9/100 (25th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
In2Bones, LLC is a focused PatentsView assignee: 6 CPC subclasses with 62.5% of grants classified under A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device). Peak complete grant year is 2020 (3 grants) versus a trough of 1 in 2018. By volume, In2bones sits between Imperial Pools, Inc. and Indeed, Inc..
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Imperial Pools, Inc.
8 patents
Implant Sciences Corporation
8 patents
Implicit, LLC
8 patents
Imprenditore Pty Ltd.
8 patents
InSilixa, Inc.
8 patents
InView Technology Corporation
8 patents
Incodema3D, LLC
8 patents
Indeed, Inc.
8 patents
In2Bones, LLC
8 patents
What this shows In2Bones holds 8 patents at rank #32,083, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #32,083 in granted patent volume.
Other assignees with the most granted patents in In2Bones's primary technology class.
In2bones's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
28 25th percentile higher than 25% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2018 | 1 | 12.5% |
| 2019 | 2 | 25.0% |
| 2020 | 3 | 37.5% |
| 2021 | 1 | 12.5% |
| 2025partial year | 1 | 12.5% |
Top 6 of 6 technology areas
Overall rank by patents
#32,031
of 49,997 tracked assignees
27.9 out of 100
What to do with this data
In2Bones, LLC's patent record in context - here's where to go next.
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.